The Male Vitality Protocol
A three-month, three-layer protocol for male fertility and sexual function — a different outcome set from raising testosterone. Layer 0 corrects measured deficiencies and the lifestyle variables that actually move sperm counts (body fat, sleep, heat, alcohol). Layer 1 is spermatogenesis support judged on a repeat semen analysis at 12 weeks: CoQ10 with meta-analytic support, shilajit and ashwagandha with single-centre pilots. Layer 2 is maca for libido and mild erectile dysfunction. Includes the WHO 2021 semen reference limits, the reasons a urologist comes before any supplement, and why TRT is the wrong tool for a man who wants children.
Daily Schedule
Timing and dosage for each step
Layer 0 — morning with a fatty meal, ONLY if 25(OH)D is below 50 nmol/L
50 mcg
2,000 IU (50 mcg), dosed to a level and retested at 12 weeks. Repletion is for the deficient man, not a fertility lever: a 330-man triple-blind trial in vitamin D-insufficient infertile men found no change in semen parameters, with a live-birth signal only in the oligozoospermic subgroup. Correct a deficiency because it is a deficiency.
Layer 0 — evening with food, ONLY if serum zinc is low
15 mg
15 mg bisglycinate, and only where zinc is measured low. ⚠️ Routine zinc is not a fertility intervention: in the 2,370-couple FAZST trial, 30 mg zinc plus 5 mg folic acid for six months did not improve semen quality or live birth (34% vs 35%) and raised sperm DNA fragmentation (29.7% vs 27.2%).
Layer 1 — 100 mg twice daily after main meals
200 mg
Purified, batch-tested for lead, arsenic, cadmium and mercury — no raw resin. The 90-day single-arm trial in 28 oligospermic men reported +61.4% total sperm count and +12.4–17.4% motility versus baseline, with no placebo arm. Grade C. Judge on a repeat semen analysis at 12 weeks, never earlier.
Layer 1 — with a fatty meal
200 mg
200 mg ubiquinol daily. The best-evidenced compound in this protocol: a 2025 meta-analysis of nine RCTs (781 men) found +10.22 million/mL sperm concentration and +4.95% total motility versus control, with morphology improving only past three months. Duration matters more than dose.
Layer 1 — 225 mg three times daily with food
675 mg
Full-spectrum root extract, 675 mg/day in three doses — the exact regimen of the 46-man placebo-controlled pilot in oligospermic men (+167% sperm count, +57% motility over 90 days from a very low baseline). One pilot, one centre, not replicated. ⚠️ Stop on any jaundice or dark urine; rare hepatotoxicity reports exist for ashwagandha products.
Layer 2 — optional, morning with food
2400 mg
2,400 mg dry extract — the dose used in the 50-man mild erectile dysfunction trial (IIEF-5 +1.6 vs +0.5 on placebo, P < 0.001). Improves sexual desire from week 8 without changing testosterone or oestradiol. This is a libido and erectile-function layer, not a fertility layer: it has no semen-parameter data.
Read This Before the Protocol
This is not a testosterone protocol. Raising total or free testosterone is a different goal with a different evidence base, and it lives in the Hormonal Optimization Stack. This protocol is for the man whose problem is fertility or sexual function — sperm count, motility, morphology, libido, erections — which overlap with testosterone far less than the supplement aisle implies.
Three things outrank every layer below.
A urologist or andrologist comes first. A varicocele is the most common correctable finding in infertile men, and its repair is one of the few male-fertility interventions with strong controlled evidence: a 2023 meta-analysis of 16 studies and 2,420 men found sperm concentration, total count, progressive motility and morphology all significantly improved after repair versus untreated controls. Obstructive causes, genetic causes, and hormonal causes (including pituitary disease) also need a diagnosis, not a capsule. No supplement in this protocol fixes an anatomical problem.
Testosterone replacement is the wrong tool for a man who wants children. Exogenous testosterone suppresses LH and FSH, collapses intratesticular testosterone, and shuts down sperm production. Most men recover within a year of stopping, but not all, and "most" is a poor bet for someone trying to conceive now. The Endocrine Society guideline explicitly recommends against starting testosterone therapy in men planning fertility in the near term. The fertility-preserving alternatives — hCG, clomiphene — are prescription decisions made by a specialist. The full reasoning is in When Lifestyle Isn't Enough: The TRT Decision Framework.
The partner's evaluation matters as much. Infertility is a couple's diagnosis. A man optimising his semen analysis for six months while his partner has an undiagnosed tubal or ovulatory problem has optimised the wrong variable.
The Layer Logic
| Layer | Purpose | Evidence grade | Judge at |
|---|---|---|---|
| 0 — Foundation | Correct measured deficiencies; body fat, sleep, heat, alcohol | B (as deficiency correction) | 12 weeks, bloods |
| 1 — Spermatogenesis | Sperm concentration, motility, morphology | C (CoQ10 B; shilajit, ashwagandha C) | 12 weeks, repeat semen analysis |
| 2 — Libido and erection | Sexual desire, mild erectile dysfunction | C | 8–12 weeks, IIEF-5 |
The protocol is graded C to its weakest load-bearing claim. CoQ10 alone would be a B. Shilajit and ashwagandha rest on single-centre trials, one of them uncontrolled, and the honest grade for a stack built on them is C.
The entry measurements are a semen analysis and a fasting morning testosterone (with SHBG, LH and FSH), plus 25(OH)D and serum zinc. Without a baseline semen analysis there is no way to judge Layer 1, because the endpoint is a number, not a feeling.
Layer 0 — Correct What Is Actually Wrong
Layer 0 is where the largest effects live, and almost none of it comes in a capsule.
Body fat. A meta-analysis of 21 studies and 13,077 men found a J-shaped relationship between BMI and low sperm count: compared with normal-weight men, the odds of oligozoospermia or azoospermia were 1.11 for overweight, 1.28 for obese and 2.04 for morbidly obese men. Weight loss in obese men also restores testosterone — the meta-analytic rise was 2.87 nmol/L with diet and 8.73 with bariatric surgery — which makes it the one lever that serves both routes.
Sleep. One week of five-hour nights lowered daytime testosterone 10–15% in young healthy men. Sleep is a hormone-production window, and no supplement compensates for a missing one.
Heat and alcohol. Scrotal heat is a recognised spermatogenesis stressor in the animal literature, and the human advice — no laptop on the lap, no daily hot tubs, no tight synthetic underwear for the three months — costs nothing. The alcohol evidence is weaker than commonly stated: a 2024 meta-analysis of 17 observational studies found no significant testosterone difference between drinkers and non-drinkers overall, with damage concentrated in alcohol use disorder. Heavy drinking is the target; a glass of wine is not.
Vitamin D and zinc — to a level, not by default. Both are in this protocol only to correct measured deficiency. Vitamin D repletion did not change semen parameters in a 330-man triple-blind trial of vitamin D-insufficient infertile men. Routine zinc plus folic acid in 2,370 couples did not improve live birth and raised DNA fragmentation. Deficiency correction is grade B; supplementation of the replete is grade D.
Layer 1 — Spermatogenesis Support, Judged at Three Months
The single most important number in this protocol is the length of spermatogenesis. The textbook cycle from spermatogonium to released sperm runs roughly ten to eleven weeks — a figure the most thorough review of human spermatogenesis argues may itself be off by about six days — followed by epididymal transit. Sperm ejaculated today began developing in early summer. Nothing started this week can be judged on a semen analysis before week 12, and a man who retests at week 6 is measuring the previous cycle.
CoQ10 — 200 mg/day. The best-supported compound here. A 2025 meta-analysis of nine randomised trials (781 men with idiopathic infertility) found CoQ10 raised sperm concentration by 10.22 million/mL, total motility by 4.95%, and seminal CoQ10 levels, with clinical pregnancy odds significantly higher (odds ratio 6.02, a wide interval from few events). Morphology improved only in trials longer than three months. A second 2024 meta-analysis of eight RCTs agreed on count, motility and morphology but found no effect on concentration — the heterogeneity is real and the effect sizes are modest.
Shilajit — 100 mg twice daily, purified. The 90-day single-arm trial in oligospermic men is described in the shilajit profile: +61.4% total sperm count, +18.9% normal forms, +23.5% testosterone, no placebo group. Buy only a product with a batch heavy-metal certificate.
Ashwagandha — 675 mg/day of full-spectrum root extract in three doses. In a 46-man placebo-controlled pilot in oligospermic men, sperm count rose from 9.59 to 25.61 million/mL (+167%), semen volume 53%, and motility from 18.6% to 29.2% over 90 days, with minimal change on placebo. From a baseline that low, a large percentage is a small absolute change, and the trial has not been replicated.
The whole layer is built on one grade B compound and two grade C pilots, and it is judged on one number: the repeat semen analysis at week 12 against the WHO 2021 lower reference limits — 16 million/mL concentration, 30% progressive motility, 42% total motility, 4% normal forms.
Layer 2 — Libido and Erectile Function
Maca is the one compound with placebo-controlled evidence for sexual desire that is independent of testosterone. In a 12-week trial in men aged 21–56, 1,500 or 3,000 mg/day improved self-reported sexual desire from week 8, with serum testosterone and oestradiol unchanged and the effect independent of depression and anxiety scores. In 50 men with mild erectile dysfunction, 2,400 mg/day for 12 weeks raised the IIEF-5 score by 1.6 points against 0.5 on placebo (P < 0.001) — a small, real, subjective effect.
Maca has no semen-parameter data and does nothing for the fertility layer. It is here because libido and erection are part of the outcome set, and because it is the one thing on this page that a man is likely to feel.
Moderate or severe erectile dysfunction is a vascular and neurological symptom that needs a clinician — it is also an early cardiovascular marker. PDE5 inhibitors outperform every supplement here, and the peptide route (PT-141) is a separate protocol in The Sexual Wellness Protocol.
When to Stop and See a Clinician
- Azoospermia or a total count below 5 million/mL on the baseline analysis — this needs genetic and hormonal evaluation now, not a 12-week supplement trial
- Low LH and FSH alongside low testosterone — secondary hypogonadism needs a pituitary work-up
- Twelve months of trying (six if the partner is over 35) without conception — the couple needs a fertility clinic regardless of how the semen analysis looks
- A palpable scrotal mass, pain, or asymmetry — examination, not supplements
- No improvement on the week-12 semen analysis — the protocol has been given its fair run; stop layering and refer
Monitoring
| Marker | When | Why |
|---|---|---|
| Semen analysis (WHO 2021) | Baseline, week 12 | The only endpoint that judges Layer 1 |
| Total testosterone, SHBG, LH, FSH | Baseline (fasting, 08:00–10:00), week 12 | Separates primary from secondary causes; a second low value confirms |
| 25(OH)D, serum zinc | Baseline, week 12 | Layer 0 is dosed to these, not to a pill count |
| ALT / AST | Baseline, week 12 | Ashwagandha hepatotoxicity is rare but documented |
| IIEF-5 | Baseline, week 8, week 12 | The validated scale for Layer 2 |
| Body weight, waist | Monthly | The largest lever in the protocol |
Log the numbers in the biomarker tracker so the week-12 comparison is against a record, not a memory.
Safety and Scope
This protocol contains no hormones and no prescription agents. It is not a substitute for a urological evaluation, and it does not treat varicocele, obstruction, genetic infertility, or hypogonadism. Shilajit must be purified and batch-tested; raw resin carries documented heavy-metal contamination. Ashwagandha has rare hepatotoxicity reports and should be stopped at any sign of liver injury. Nothing here is appropriate during a partner's assisted-reproduction cycle without the treating clinic's knowledge.
Men whose goal is testosterone rather than fertility should use the Hormonal Optimization Stack instead — the two protocols are alternatives, not layers, and the reasons are in Natural Testosterone Optimization: What Actually Works.